Coupling of this nanobody to an anti-MUC-1 61 or an anti-CEA 193,194 nanobody was shown to mediate tumor growth inhibition when injected on a daily basis in mice receiving peripheral blood mononuclear cells and xenografted with MUC-1+ or CEA+ colon carcinoma tumors. This evidence concerns the gene CEACAM5 and neoplasm.